Suchergebnisse - "Sarilumab"

PubPharm (13)

1

Pharmacological treatment of COVID-19 : an opinion paper

enthalten in: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia | 2022

von García-Lledó, A. | Gómez-Pavón, J. | González Del Castillo, J. | +12

2

Management of hepatitis B virus reactivation due to treatment of COVID-19

enthalten in: Hepatology international | 2022

von Yip, T. | Gill, M. | Wong, G. | +1

3

Drug dosing in hospitalized obese patients with COVID-19

enthalten in: Critical care (London, England) | 2022

von Barletta, J. | Erstad, B.

4

Drug dosing in hospitalized obese patients with COVID-19

enthalten in: Critical care | 2022

von Barletta, J. | Erstad, B.

5

Drug dosing in hospitalized obese patients with COVID-19

enthalten in: Critical care | 2022

von Barletta, J. | Erstad, B.

6

Management of hepatitis B virus reactivation due to treatment of COVID-19

enthalten in: Hepatology international | 2022

von Yip, T. | Gill, M. | Wong, G. | +1

7

Management of hepatitis B virus reactivation due to treatment of COVID-19

enthalten in: Hepatology international | 2022

von Yip, T. | Gill, M. | Wong, G. | +1

8

Management of hepatitis B virus reactivation due to treatment of COVID-19

enthalten in: Hepatology international | 2022

von Yip, T. | Gill, M. | Wong, G. | +1

9

Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis : the ANSWER cohort study

enthalten in: Clinical rheumatology | 2021

von Ebina, K. | Hirano, T. | Maeda, Y. | +16

10

Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study

enthalten in: Clinical rheumatology | 2021

von Ebina, K. | Hirano, T. | Maeda, Y. | +16